Who Buys Cefixime from India — 1805 Importers Behind a $173.9M Market
India's cefixime import market is served by 1805 active buyers who collectively imported $173.9M across 8,398 shipments. SAAM GROUP LTD (AFGHANISTAN) leads with a 4.3% market share, followed by M/S. PRINCE PHARMA DEPOT PHARMACETI and M/S. T.CHOITHRAM AND SONS (LIB) INC. The top 5 buyers together control 16.0% of total import value, reflecting a moderately competitive buyer landscape.
Top Cefixime Importers — Ranked by Import Value
SAAM GROUP LTD (AFGHANISTAN) is the leading cefixime importer from India, holding a 4.3% share of the $173.9M market across 8,398 shipments from 1805 buyers. The top 5 buyers — SAAM GROUP LTD (AFGHANISTAN), M/S. PRINCE PHARMA DEPOT PHARMACETI (CONGO DR), M/S. T.CHOITHRAM AND SONS (LIB) INC (LIBERIA), AL-KAWKAB SCIENTIFIC BUREAU (JORDAN), AL KAWKAB SCIENTIFIC BUREAU (JORDAN) — collectively control 16.0% of total import value.
Top Cefixime Buyers & Importers
Ranked by import value · 1805 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | SAAM GROUP LTDAFGHANISTAN BACTOFIX DS DRY SYRUP (CEFIXIME FOR ORALBACTOFIX 400 TABLETS (CEFIXIME TABLETS UBACTOFIX 100 DRY SYRUP (CEFIXIME ORAL SU | $7.6M | 5 | 4.3% |
| 2 | M/S. PRINCE PHARMA DEPOT PHARMACETICONGO DR PHARMACEUTICAL PRODUCTS:CEFILIM CEFIXIMECEFIXIME CAPSULE 400 MG CEFIXIME CAPSULEUSP 400 MGSAFIX DS B. | $6.0M | 5 | 3.4% |
| 3 | M/S. T.CHOITHRAM AND SONS (LIB) INCLIBERIA PHARMACEUTICAL PRODUCTS:CEFILIM CEFIXIMECEFIXIME CAPSULE 400 MG CEFIXIME CAPSULEUSP 400 MGSAFIX DS B. | $5.5M | 5 | 3.2% |
| 4 | AL-KAWKAB SCIENTIFIC BUREAUJORDAN SUPIXIME-100 DRY SYRUP (CEFIXIME FOR ORASUPIXIME 400 - TAX INVOICE NO: 707202202 DT: 31.05.2024 | $5.5M | 5 | 3.2% |
| 5 | AL KAWKAB SCIENTIFIC BUREAUJORDAN PHARMACEUTICAL PRODUCTS:CEFILIM CEFIXIMEBACTOFIX DS DRY SYRUP (CEFIXIME FOR ORALCEFINO-100 TAB. BO | $3.3M | 5 | 1.9% |
| 6 | MULTIPHARMLEBANON | $2.9M | 5 | 1.6% |
| 7 | YAR PYE COMPANY LIMITEDMYANMAR BACTOFIX DS DRY SYRUP (CEFIXIME FOR ORALCEFINO-100 TAB. BOBACTOFIX 400 TABLETS (CEFIXIME TABLETS U | $2.7M | 5 | 1.5% |
| 8 | PLANET PHARMAFRANCE CEFOLAC 200MG CPR PELL B/8 (CEFIXIME TABXIMCLAV 200MG/125MG TABLETSCEFIXIME CAPSULES 400MG | $2.6M | 5 | 1.5% |
| 9 | PLANETPHARMAFRANCE CEFOLAC 200MG CPR PELL B/8 (CEFIXIME TABXIMCLAV 200MG/125MG TABLETSCEFIXIME CAPSULES 400MG | $2.3M | 5 | 1.3% |
| 10 | MYLAN IRELAND LIMITED,FRANCE CEFOLAC 200MG CPR PELL B/8 (CEFIXIME TABXIMCLAV 200MG/125MG TABLETSCEFIXIME CAPSULES 400MG | $1.8M | 5 | 1.0% |
| 11 | KAWKAB SCIENTIFIC BUREAUIRAQ SUPIXIME-100 DRY SYRUP (CEFIXIME FOR ORASUPIXIME 400 - TAX INVOICE NO: 707202202 DT: 31.05.2024 | $1.8M | 5 | 1.0% |
| 12 | TO THE DIRECTOR OFSUDAN PHARMACEUTICAL PRODUCTS:CEFILIM CEFIXIMEBACTOFIX DS DRY SYRUP (CEFIXIME FOR ORALCEFINO-100 TAB. BO | $1.7M | 5 | 1.0% |
| 13 | LABOREX UGANDA LIMITEDKENYA CEFIXIME CAPSULE 400 MG CEFIXIME CAPSULEUSP 400 MGVIREXIM 400 CAPSULE CEFIXIME 400 MG CAPSULE | $1.7M | 5 | 1.0% |
| 14 | BEWETRLLUNITED ARAB EMIRATES | $1.7M | 5 | 1.0% |
| 15 | AURO PHARMA INC,CANADA CEFIXIME CAPSULES 400MG USA - 1BTL X 50 CAPSCEFIXIME CAPSULES 400MG USA - 1 BTL X 50 CAPSCEFIXIME CAPSULES 400MG -BLISTER USA - 1 BOX X 10 CAPS | $1.6M | 5 | 0.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Cefixime — and from which countries?
Flow of Cefixime exports from India: each country's share and the named importers behind the numbers
Cefixime — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1France
France emerges as the first largest importing country, achieving a total trade value of $19.7M through 302 shipments. This represents a market share of 11.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• PLANET PHARMA - $2.6M (13.1% of country's total business)
• PLANETPHARMA - $2.3M (11.5% of country's total business)
• MYLAN IRELAND LIMITED, - $1.8M (9.3% of country's total business)
• PLANETPHARMA SA - $1.3M (6.8% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $65.1K, indicating premium pricing strategy compared to the market average of $20.7K.
France is a key market for Cefixime imports, representing 11.3% of total trade value.
2United States
United States emerges as the second largest importing country, achieving a total trade value of $12.3M through 0 shipments. This represents a market share of 7.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: United States demonstrates strong market positioning with an average shipment value of $12.3M, indicating premium pricing strategy compared to the market average of $20.7K.
United States is a key market for Cefixime imports, representing 7.1% of total trade value.
3Philippines
Philippines emerges as the third largest importing country, achieving a total trade value of $10.5M through 0 shipments. This represents a market share of 6.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $10.5M, indicating premium pricing strategy compared to the market average of $20.7K.
Philippines is a key market for Cefixime imports, representing 6.1% of total trade value.
4Afghanistan
Afghanistan emerges as the fourth largest importing country, achieving a total trade value of $10.3M through 48 shipments. This represents a market share of 5.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Afghanistan has a diverse importer base, with their top importers including:
• SAAM GROUP LTD - $7.6M (73.2% of country's total business)
Key Insight: Afghanistan demonstrates strong market positioning with an average shipment value of $215.1K, indicating premium pricing strategy compared to the market average of $20.7K.
Afghanistan is a key market for Cefixime imports, representing 5.9% of total trade value.
5Kenya
Kenya emerges as the fifth largest importing country, achieving a total trade value of $8.8M through 66 shipments. This represents a market share of 5.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Kenya has a diverse importer base, with their top importers including:
• LABOREX UGANDA LIMITED - $1.7M (18.8% of country's total business)
Key Insight: Kenya demonstrates strong market positioning with an average shipment value of $134.0K, indicating premium pricing strategy compared to the market average of $20.7K.
Kenya is a key market for Cefixime imports, representing 5.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Cefixime buyer market intelligence
1Buyer Segment Analysis
The importation of Cefixime from India involves a diverse array of buyers, each with distinct procurement behaviors and order patterns. Based on TransData Nexus data from 2022 to 2026, we can classify the top 10 buyers into the following segments:
1. Distributors: Entities such as SAAM GROUP LTD (Afghanistan), M/S. PRINCE PHARMA DEPOT PHARMACETI (Congo DR), and M/S. T.CHOITHRAM AND SONS (LIB) INC (Liberia) fall into this category. These organizations typically purchase large volumes of Cefixime to supply to various healthcare providers, including pharmacies and hospitals, within their respective regions. Their procurement patterns are characterized by bulk orders aimed at maintaining a steady supply chain to meet market demand.
2. Hospital Groups: While specific hospital groups are not explicitly listed among the top buyers, it's common for such entities to procure medications directly or through affiliated distributors. Their purchasing behavior often involves regular, sizable orders to ensure the availability of essential medicines for patient care.
3. Retail Chains: Similar to hospital groups, large pharmacy chains may not be directly named but are integral to the distribution network. They typically engage in consistent procurement to stock their outlets, ensuring that medications like Cefixime are readily available to consumers.
4. Government Procurement: Organizations such as AL-KAWKAB SCIENTIFIC BUREAU (Jordan) may represent government-affiliated procurement bodies responsible for sourcing medicines for public healthcare facilities. Their purchasing patterns often involve tender-based systems, focusing on cost-effectiveness and compliance with national healthcare policies.
5. Re-exporters: Entities like PLANET PHARMA and PLANETPHARMA (both in France) might function as re-exporters, importing Cefixime for distribution to other markets. Their procurement behavior includes strategic purchasing to capitalize on market demands in various regions, often involving complex logistics and regulatory compliance.
6. Contract Manufacturers: MYLAN IRELAND LIMITED (France) is an example of a contract manufacturer that imports Cefixime as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is typically aligned with production schedules and market forecasts, ensuring timely manufacturing and distribution.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Cefixime buyer market intelligence
1Country-Specific Import Regulations
Navigating the import regulations for Cefixime in the top importing countries is essential for compliance and market entry. Below is an overview for each country:
1. France:
2. United States:
3. Philippines:
4. Afghanistan:
5. Kenya:
Compliance with these regulations is vital for successful market entry and sustained operations within these countries.
Demand Drivers & Market Opportunity
TransData Nexus Cefixime buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cefixime in importing countries is influenced by several key factors:
1. Disease Prevalence: Cefixime is commonly used to treat bacterial infections such as gonorrhea, respiratory tract infections, and urinary tract infections. High prevalence rates of these conditions in various regions drive the demand for effective antibiotics.
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, Kenya's Mission for Essential Drugs and Supplies (MEDS) procures and supplies essential medicines to healthcare facilities, ensuring availability and affordability.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines. In the Philippines, the expansion of the National Health Insurance Program has enhanced access to medications like Cefixime.
4. WHO Essential Medicines List Procurement: Cefixime's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating priority health conditions, prompting countries to prioritize its procurement.
5. Tender-Based Purchasing: Many governments and organizations utilize tender-based systems to procure medicines, ensuring competitive pricing and quality assurance. This approach is prevalent in countries like France and Kenya, where public procurement processes are standardized to maintain supply chain integrity.
With 1,805 buyers across 131 countries, the global market for Cefixime presents substantial opportunities. Understanding the specific demand drivers in each region enables targeted strategies to effectively meet market needs.
Common Questions — Cefixime Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest cefixime buyer importing from India?
Based on import volume and value, SAAM GROUP LTD (AFGHANISTAN) leads with $7.6M in imports and a 4.3% market share — the highest of any single cefixime importer. M/S. PRINCE PHARMA DEPOT PHARMACETI (CONGO DR) and M/S. T.CHOITHRAM AND SONS (LIB) INC (LIBERIA) are the next largest buyers.
QHow many companies buy cefixime from India?
There are 1805 active cefixime buyers importing from India, with a combined market of $173.9M across 8,398 shipments to 131 countries. The top 5 buyers hold 16.0% of total import value, while the remaining 1800 buyers handle the other 84.0%.
QWhich countries import the most cefixime from India?
The top importing countries for cefixime from India are France (11.3%), United States (7.1%), Philippines (6.1%), Afghanistan (5.9%), Kenya (5.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of cefixime, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for cefixime from India?
The average import transaction value for cefixime from India is $20.7K, with an average unit price of $6.16 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Cefixime buyer market intelligence
1Buyer Segment Analysis
The importation of Cefixime from India involves a diverse array of buyers, each with distinct procurement behaviors and order patterns. Based on TransData Nexus data from 2022 to 2026, we can classify the top 10 buyers into the following segments:
1. Distributors: Entities such as SAAM GROUP LTD (Afghanistan), M/S. PRINCE PHARMA DEPOT PHARMACETI (Congo DR), and M/S. T.CHOITHRAM AND SONS (LIB) INC (Liberia) fall into this category. These organizations typically purchase large volumes of Cefixime to supply to various healthcare providers, including pharmacies and hospitals, within their respective regions. Their procurement patterns are characterized by bulk orders aimed at maintaining a steady supply chain to meet market demand.
2. Hospital Groups: While specific hospital groups are not explicitly listed among the top buyers, it's common for such entities to procure medications directly or through affiliated distributors. Their purchasing behavior often involves regular, sizable orders to ensure the availability of essential medicines for patient care.
3. Retail Chains: Similar to hospital groups, large pharmacy chains may not be directly named but are integral to the distribution network. They typically engage in consistent procurement to stock their outlets, ensuring that medications like Cefixime are readily available to consumers.
4. Government Procurement: Organizations such as AL-KAWKAB SCIENTIFIC BUREAU (Jordan) may represent government-affiliated procurement bodies responsible for sourcing medicines for public healthcare facilities. Their purchasing patterns often involve tender-based systems, focusing on cost-effectiveness and compliance with national healthcare policies.
5. Re-exporters: Entities like PLANET PHARMA and PLANETPHARMA (both in France) might function as re-exporters, importing Cefixime for distribution to other markets. Their procurement behavior includes strategic purchasing to capitalize on market demands in various regions, often involving complex logistics and regulatory compliance.
6. Contract Manufacturers: MYLAN IRELAND LIMITED (France) is an example of a contract manufacturer that imports Cefixime as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is typically aligned with production schedules and market forecasts, ensuring timely manufacturing and distribution.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Cefixime buyer market intelligence
1Country-Specific Import Regulations
Navigating the import regulations for Cefixime in the top importing countries is essential for compliance and market entry. Below is an overview for each country:
1. France:
2. United States:
3. Philippines:
4. Afghanistan:
5. Kenya:
Compliance with these regulations is vital for successful market entry and sustained operations within these countries.
Demand Drivers & Market Opportunity
TransData Nexus Cefixime buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cefixime in importing countries is influenced by several key factors:
1. Disease Prevalence: Cefixime is commonly used to treat bacterial infections such as gonorrhea, respiratory tract infections, and urinary tract infections. High prevalence rates of these conditions in various regions drive the demand for effective antibiotics.
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, Kenya's Mission for Essential Drugs and Supplies (MEDS) procures and supplies essential medicines to healthcare facilities, ensuring availability and affordability.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines. In the Philippines, the expansion of the National Health Insurance Program has enhanced access to medications like Cefixime.
4. WHO Essential Medicines List Procurement: Cefixime's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating priority health conditions, prompting countries to prioritize its procurement.
5. Tender-Based Purchasing: Many governments and organizations utilize tender-based systems to procure medicines, ensuring competitive pricing and quality assurance. This approach is prevalent in countries like France and Kenya, where public procurement processes are standardized to maintain supply chain integrity.
With 1,805 buyers across 131 countries, the global market for Cefixime presents substantial opportunities. Understanding the specific demand drivers in each region enables targeted strategies to effectively meet market needs.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 1805 global importers of Cefixime identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 8,398 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 131 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,398 Verified Shipments
1805 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists